Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer

Conditions:   Anatomic Stage IV Breast Cancer AJCC v8;   Prognostic Stage IV Breast Cancer AJCC v8 Interventions:   Biological: Pembrolizumab;   Drug: Tamoxifen;   Drug: Vorinostat Sponsors:   University of California, San Francisco;   Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials